Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. (Q40475236)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. |
scientific article |
Statements
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial (English)
Elena Oldani
Alessandro Rambaldi
Anna Grassi
Arianna Masciulli
Maria Caterina Micò
Benedetto Bruno
Irene Cavattoni
Stella Santarone
Roberto Raimondi
Mauro Montanari
Patrizia Chiusolo
Domenico Pastore
Stefano Guidi
Francesca Patriarca
Antonio M Risitano
Giorgia Saporiti
Elisabetta Terruzzi
William Arcese
Giuseppe Marotta
Angelo Michele Carella
Arnon Nagler
Domenico Russo
Emilio Paolo Alessandrino
Giovanni Fernando Torelli
Rosanna Scimè
Nicola Mordini
Rosa Maria Marfisi
Andrea Bacigalupo
28 September 2015